16 July 2024 : Original article
Ginkgetin Pretreatment Reduces Inflammatory Response in DCD Donor Liver via JAK2/STAT3 Signaling Pathway
Jia LiuBCDE, Jiansheng XiaoAG, Qin DengBC, ZhiHui FuCD, Qi XiaoAFGDOI: 10.12659/AOT.944153
Ann Transplant 2024; 29:e944153
Figure 5 Ginkgetin inhibited the inflammatory response of DCD donor livers through the JAK2/STAT3 signaling pathway. mRNA expression level in liver of IL-1β (A), IL-10 (B) and TNF-α (C) were tested by real-time PCR. Data are presented as mean±SD, * P<0.05, ** P<0.01, and *** P<0.001. n=5 per group. All statistical analysis were performed using GraphPad Prism 8.0.1 software (San Diego, CA, USA).